This Is MS Multiple Sclerosis Community: Knowledge & Support

Healthtalk.com Hosts Free Patient Webcast on Multiple Sclerosis and the FDA's Reapproval of Tysabri June 22nd, 8:30 PM (Eastern)

Program to Feature Prominent MS Experts Discussing the Drug and What It Means for Consumers

SEATTLE, June 15 /PRNewswire/ --

WHAT: HealthTalk Inc., a pioneer in patient education delivering live
and web-based programs on the latest treatments and research
news, is hosting a live webcast for Multiple Sclerosis
patients, their families and caregivers. Experts will be
discussing the recall and the re-approval of the drug Tysabri
as well as its benefits, safety and risk management.
Consumers can participate via the live webcast or by phone.

WHY: There are more than 400,000 people who have been diagnosed with
Multiple Sclerosis in the U.S. The drug Tysabri has recently
been approved by the FDA for re-release for use in patients
with relapsing forms of MS.

WHO: Howard Rossman, D.O., F.A.C.N. Dr. Rossman spearheaded the
creation of the M.I.N.D. Multiple Sclerosis Center located in
Farmingham Hills, MI and serves as Medical Director of the
Center which presently services over 1,800 patients with MS.

WHEN: Thursday, June 22nd 2006
8:30 PM (Eastern)
5:30 PM (Pacific)

WHERE: Register online at http://www.healthtalk.com/msprogram or
call 1-800-522-3254.

COST: Free

Press Contact:
Alyssa Schaier, 914-589-6904
aschaier@informedmedical.com

_________________
Dunmann.